Veerle Vanheusden
Ghent University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Veerle Vanheusden.
Journal of Biological Chemistry | 2003
Ahmed Haouz; Veerle Vanheusden; Hélène Munier-Lehmann; Mattheus Froeyen; Piet Herdewijn; Serge Van Calenbergh; Marc Delarue
The chemical synthesis of new compounds designed as inhibitors of Mycobacterium tuberculosis TMP kinase (TMPK) is reported. The synthesis concerns TMP analogues modified at the 5-position of the thymine ring as well as a novel compound with a six-membered sugar ring. The binding properties of the analogues are compared with the known inhibitor azido-TMP, which is postulated here to work by excluding the TMP-bound Mg2+ ion. The crystallographic structure of the complex of one of the compounds, 5-CH2OH-dUMP, with TMPK has been determined at 2.0 Å. It reveals a major conformation for the hydroxyl group in contact with a water molecule and a minor conformation pointing toward Ser99. Looking for a role for Ser99, we have identified an unusual catalytic triad, or a proton wire, made of strictly conserved residues (including Glu6, Ser99, Arg95, and Asp9) that probably serves to protonate the transferred PO3 group. The crystallographic structure of the commercially available bisubstrate analogueP 1-(adenosine-5′)-P 5-(thymidine-5′)-pentaphosphate bound to TMPK is also reported at 2.45 Å and reveals an alternative binding pocket for the adenine moiety of the molecule compared with what is observed either in the Escherichia coli or in the yeast enzyme structures. This alternative binding pocket opens a way for the design of a new family of specific inhibitors.
Journal of Medicinal Chemistry | 2003
Veerle Vanheusden; Hélène Munier-Lehmann; Matheus Froeyen; Laurence Dugué; Arne Heyerick; Denis De Keukeleire; Sylvie Pochet; Roger Busson; Piet Herdewijn; Serge Van Calenbergh
Journal of Medicinal Chemistry | 2004
Veerle Vanheusden; Hélène Munier-Lehmann; Matheus Froeyen; Roger Busson; Jef Rozenski; Piet Herdewijn; Serge Van Calenbergh
Bioorganic & Medicinal Chemistry Letters | 2002
Veerle Vanheusden; Hélène Munier-Lehmann; Sylvie Pochet; Piet Herdewijn; Serge Van Calenbergh
Bioorganic & Medicinal Chemistry Letters | 2003
Veerle Vanheusden; Philippe Van Rompaey; Hélène Munier-Lehmann; Sylvie Pochet; Piet Herdewijn; Serge Van Calenbergh
Journal of Organic Chemistry | 2004
Veerle Vanheusden; Roger Busson; Piet Herdewijn; Serge Van Calenbergh
Archive | 2003
Ahmed Haouz; Veerle Vanheusden; Mattheus Froeyen; Piet Herdewijn; Serge Van Calenbergh; Marc Delarue
European Journal of Organic Chemistry | 2003
Philippe Van Rompaey; Koen Nauwelaerts; Veerle Vanheusden; Jef Rozenski; Hélène Munier-Lehmann; Piet Herdewijn; Serge Van Calenbergh
Journal of Medicinal Chemistry | 2002
Serge Van Calenbergh; Andreas Link; Shelly Fujikawa; Rianne A.F. de Ligt; Veerle Vanheusden; Abolfasl Golisade; Norbert Blaton; Jef Rozenski; A. P. Ijzerman; Piet Herdewijn
Collection of Czechoslovak Chemical Communications | 1999
Serge Van Calenbergh; Andreas Link; Shelly Fujikawa; Veerle Vanheusden; Denis De Keukeleire; Adriaan P. IJzerman; Piet Herdewijn